Solid Biosciences
SLDB
SLDB
91 hedge funds and large institutions have $184M invested in Solid Biosciences in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
37% less capital invested
Capital invested by funds: $293M → $184M (-$109M)
Holders
91
Holding in Top 10
–
Calls
$567K
Puts
$527K
Top Buyers
| 1 | +$1.79M | |
| 2 | +$1.06M | |
| 3 | +$890K | |
| 4 |
Goldman Sachs
New York
|
+$634K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$284K |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$2.24M | |
| 3 | -$2.21M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$1.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1M |